Kadans Science Partner is pleased to welcome Eurofins to At The Park. A new lab facility is currently being set up on the innovative campus in Rijswijk in record time. With the 2,200 m2
Date: Tuesday November 24 Time: 13.00 - 14.30 CET Where: Online In collaboration with Briskr Over the last months it has become clear that the Covid-19 pandemic has a major impact on our lives
EIT InnoEnergy aims to drag start-ups that it invests in as well as it can through the corona crisis. Read how they go about that in this series. What is the impact of COVID-19
VIROCLINICS-DDL is pleased to announce the signing of a new collaboration agreement with REPROCELL. REPROCELL will provide sample processing services to VIROCLINICS-DDL to support several clinical research projects. VIROCLINICS-DDL is the global leader in clinical trial management services, focused on viral
Save the Date: How Covid-19 Pandemic boosts innovation and new business (From Molecule to Business Event) Event information Date: Thursday September 24 Time: 14:00 – 16:00 Where: Hybrid event (onsite at NTC Nijmegen
Kadans Connected - Return to the lab “How to manage your lab activities during and after a pandemic” Tuesday June 16, the fifth edition in a series of successful Kadans Connected webinars took place.
Event information Date: Tuesday June 16 Time: 10:00 – 11:00 AM CEST Where: Online 86% of Kadans Connected participants have indicated they found the webinars (very) useful. Are you joining our next online event?
CEPI, the Coalition for Epidemic Preparedness Innovations, is today issuing a new Call for Proposals inviting organizations around the world to apply for funding to speed up development, scale-up manufacturing capacity, and expand the geographical footprint
Event information Date: Tuesday June 9 Time: 11:00 – 12:00 AM CEST Where: Online Following a number of successful editions of Kadans Connected, another webinar will be organized on Tuesday June 9. During
Event information Briskr webinar Date: Tuesday June 16 Time: 13:30 – 15:00 Where: Online Making a good & viable business and financial plan is in itself a complicated process, especially for early stage companies.
